Abstract
Introduction: Cigarette smoking increases both the risk for insulin resistance and amyloid-β (Aβ) aggregation, and impaired brain insulin/insulin-like growth factor 1 (IGF1) signaling might increase risk factors for Alzheimer's disease (AD). We aimed to investigate the association among cerebrospinal fluid (CSF) insulin sensitivity/IGF1, glucose/lactate, and Aβ42 and further explore whether insulin sensitivity contributed to the risk for AD in active smokers. Methods: In this cross-sectional study, levels of insulin, IGF1, and lactate/glucose of 75 active smokers and 78 nonsmokers in CSF were measured. Three polymorphisms regulating IGF1 were genotyped. Analysis of variance was used to compare differences of variables between groups. Partial correlation was performed to test the relationship between CSF biomarkers and smoking status. General linear models were applied to test the interaction of the effect of single nucleotide polymorphisms and cigarette smoking on CSF IGF1 levels. Results: In the CSF from active smokers, IGF1 and lactate levels were significantly lower (p =.016 and p =.010, respectively), whereas Aβ42 (derived from our earlier research) and insulin levels were significantly higher (p
Author supplied keywords
Cite
CITATION STYLE
Wang, F., Li, H., Kong, T., Shan, L., Guo, J., Wu, Y., … Liu, Y. (2024). Association of cigarette smoking with cerebrospinal fluid biomarkers of insulin sensitivity and neurodegeneration. Brain and Behavior, 14(2). https://doi.org/10.1002/brb3.3432
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.